The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.
The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.
The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.
When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.
William Shatner and LifeWave CEO David Schmidt share lessons from his “world’s oldest intern” experience and offer advice for young professionals starting out.
The Live Nation ruling is in. Diana Moss of the Progressive Policy Institute joins us to unpack what it means for competition, consumers, and live music.
Madison Air CEO Jill Wyant on taking a century-old HVAC giant public and what the IPO means for the industry, investors, and the future of the company.
